Cogstate Ltd · ASX:CGS
Cogstate — Shareholder Meeting (October 2016)
16 slides from Cogstate's shareholder meeting presentation, Oct 17, 2016
Slide 1: Annual General Meeting 17 October 2016
For personal use only ANNUAL GENERAL MEETING 17 OCTOBER 2016
Slide 2: Board of Directors
BOARD OF DIRECTORS For personal use only • MARTYN MYER AO - Chairman Founder with long history of supporting neurosciences in Aust. • DAVID SIMPSON - Independent Non-Executive Director Previously Senior Partner at Doremus Communications, the largest US business to business advertising agency. From 1
Slide 3: We believe that brain health is profoundly important to quality of life
We believe that brain health is profoundly important to quality of life and should be easier to measure. For personal use only That’s why we so passionately apply our expertise, access to data and flexible technology to simplify the measurement of cognition. It’s our core focus, and we won’t stop unt
Slide 4: Simplifying the Measurement of Cognition In:
SIMPLIFYING THE MEASURMENT OF COGNITION IN: For personal use only © 2015 Cogstate Ltd. All rights reserved. 4
Slide 5: Validated Through Use in Over 1,500 Studies
VALIDATED THROUGH USE IN OVER 1,500 STUDIES ACROSS ACADEMIC AND CLINICAL RESEARCH For personal use only © 2015 Cogstate Ltd. All rights reserved. 5
Slide 6: FY16 Business Milestones
FY16 BUSINESS MILESTONES For personal use only RETURN TO RECORD SALES STRONG OPERATIONAL CONTRIBUTIONS FROM PROFITABILITY CONTRACTS OF DELIVERY DRIVING NEW PRODUCT US$28.5 MILLION REPEAT BUSINESS Delivered on our guidance First full year contribution to return to positive EBIT, Another record year f
Slide 7: Summary of FY16 Financial Performance
SUMMARY OF FY16 FINANCIAL PERFORMANCE For personal use only RECORD REVENUES & MAINTAINED GROSS FINANCIAL LEVERAGE POSITIVE EBIT MARGIN THE INCREASE IN REVENUE HAS EVEN AS HEADCOUNT GREW TO DELIVERED SIGNIFICANT EBIT DELIVERED ON GUIDANCE WITH KEEP PACE WITH DEMAND IMPROVEMENT EBIT OF A$1.0M FY16 FY1
Slide 8: Business Update Q1 FY17
BUSINESS UPDATE Q1 FY17 For personal use only RECORD REVENUE RECORD SALES RECORD BACKLOG MANAGING CONTINUED CASHFLOW PROFITABILITY Q1 revenue was Largest quarter of Record high a record A$11.1M new contract contracted future A Net Operating Positive EBIT signings revenue position Cash Outflow of rec
Slide 9: Continued Growth in Sales Contracts
CONTINUED GROWTH IN SALES CONTRACTS For personal use only 30,000,000 Q1 RECORD FOLLOWS 25,000,000 STRONG GROWTH IN FY16 20,000,000 US$28.5M of sales contracts signed during FY16 15,000,000 A record US$17.3M of sales contracts signed during the first quarter of FY17. 10,000,000 5,000,000 - FY09 FY10
Slide 10: Growth in Contracted Revenue
GROWTH IN CONTRACTED REVENUE For personal use only 30,000,000 RECORD CONTRACTED REVENUE BACKLOG 25,000,000 FY16: • Began year with A$10.9M of 20,000,000 contracted revenue. • An additional A$16.3M of 15,000,000 revenue was recognised as a result of signing US$28.5M of sales contracts throughout the
Slide 11: Business Outlook
BUSINESS OUTLOOK For personal use only • Positive EBIT expected for H1 FY17, based on strong Q1 performance – September quarter sales results reinforces the exciting growth profile – Strong backlog of contracted future revenue provides visibility into revenue growth for FY17 • Guidance in respect of
Slide 12: Cogstate: Assess + Monitor « Improve
For personal use only COGSTATE ASSESS + MONITOR « IMPROVE
Slide 13: Contracted Revenue Pipeline
APPENDIX 1 CONTRACTED REVENUE PIPELINE For personal use only US$17.3m of new sales contracts signed since 1 July 2016 have added an additional A$11.2m to FY17 contracted revenue. This is in addition to the A$17.5m that was secured at 1 July 2016: As at As at As at 30 Sept 2016 30 June 2016 22 Oct 20
Slide 14: Contracts Signed vs. Revenue, Per Quarter
APPENDIX 2 CONTRACTS SIGNED VS. REVENUE, PER QUARTER For personal use only 25,000,000 20,000,000 15,000,000 10,000,000 5,000,000 0 Sep-13 Dec-13 Mar-14 Jun-14 Sep-14 Dec-14 Mar-15 Jun-15 Sep-15 Dec-15 Mar-16 Jun-16 Sep-16 Contracts Executed A$ Revenue Recognised A$ © 2015 Cogstate Ltd. All rights re
Slide 15: Quarterly Book-to-Bill Ratio
APPENDIX 3 QUARTERLY BOOK-TO-BILL RATIO For personal use only New contract signings in QUARTERLY BOOK-TO-BILL RATIO 1Q17 of A$22.6m exceeded 4.50 the A$11.1m of revenue in the 4.00 3.50 same period by 2.04x (Book- Future Growth 3.00 to-Bill ratio). New contract 2.50 signings have exceeded 2.00 1.50
Slide 16: Summary Balance Sheet
APPENDIX 4 SUMMARY BALANCE SHEET For personal use only 30 JUNE 2016 30 JUN 2015 A$’000,000 A$’000,000 Assets - Cash and cash equivalents 7.47 5.50 - Trade and other receivables 5.26 4.90 - Other current assets 0.94 0.46 - Property, plant and equipment 1.71 1.12 - Deferred tax assets 3.85 1.94 - Inta